Passage Bio, Inc.
PASG
$4.59
$0.020.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.79M | 4.92M | 4.35M | 4.52M | 6.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.88M | 10.34M | 8.66M | 10.33M | 13.82M |
| Operating Income | -8.88M | -10.34M | -8.66M | -10.33M | -13.82M |
| Income Before Tax | -7.56M | -12.98M | -7.75M | -9.39M | -15.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.56M | -12.98M | -7.75M | -9.39M | -15.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.56M | -12.98M | -7.75M | -9.39M | -15.41M |
| EBIT | -8.88M | -10.34M | -8.66M | -10.33M | -13.82M |
| EBITDA | -8.75M | -10.16M | -8.47M | -10.17M | -13.62M |
| EPS Basic | -2.36 | -4.08 | -2.44 | -2.96 | -4.87 |
| Normalized Basic EPS | -1.60 | -1.86 | -1.52 | -1.85 | -2.52 |
| EPS Diluted | -2.36 | -4.08 | -2.44 | -2.96 | -4.87 |
| Normalized Diluted EPS | -1.60 | -1.86 | -1.52 | -1.85 | -2.52 |
| Average Basic Shares Outstanding | 3.21M | 3.18M | 3.18M | 3.17M | 3.16M |
| Average Diluted Shares Outstanding | 3.21M | 3.18M | 3.18M | 3.17M | 3.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |